Cognizant beat on both earnings and revenue Wednesday, extending a streak of consistent outperformance while signaling that ...

Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congress ...

Anthropic’s Claude AI shows early signs of self-awareness in a groundbreaking study, raising urgent questions about ...

Ferring Pharmaceuticals announced today that three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 101st Annual Meeting of the Western Section of the American ...

Researchers at FOM Institute for Atomic and Molecular Physics (AMOLF) in the Netherlands have developed a new type of soft, flexible material that can perform complex calculations, much like computers ...

GeneVentiv Therapeutics, Inc., a privately held biotechnology company developing one-time gene therapies for rare and inherited diseases, today announced that it held a successful INTERACT meeting ...

Okay: Lyft CEO David Risher. Here we go. This interview has been lightly edited for length and clarity. David Risher, you’re the CEO of Lyft. Welcome to Decoder.

Adobe MAX - The Creativity Conference October 28, 2025 4:30 PM EDTCompany ParticipantsDoug ClarkShantanu Narayen - Chairman & ...

Remediation of common vulnerabilities and exposures (CVEs) has become table stakes for companies to do business, because ...

This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...

The Java virtual machine provides a high-performance, universal runtime for a wealth of popular languages beyond just Java. In this article, we’ll look at the characteristic strengths and common use ...

Poster presentation outlines potential of CD3 Switch-DARPin T cell engager (TCE) using an AND-gate to overcome limitations of other TCEs Demonstrated selective T cell cytotoxicity against cells co-exp ...